Innovative Research

The innovative CRO company specialized in high-end in vitro models of neurodegenerative diseases and drug development

EVENTS

Preclinical services

Neuro-Sys has developed specific preclinical in vitro models of CNS and PNS diseases to achieve high-quality efficacy pharmacology as well as mode of action studies, a unique cost-effective strategy to accurately determine the pharmacological profiling of lead compounds and explore their underlying mechanism of action. We provide studies to determine the neuroprotective activity of lead compounds but also of dietary supplements and medical nutrition.
We are dedicated to providing high-level technical expertise and preclinical CRO services in a collaborative relationship with our clients, mainly focusing on :

› Alzheimer’s disease (AD)
› Parkinson’s disease (PD)
› Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease)
› Multiple Sclerosis (MS)
› Peripheral Neuropathies

NEURO-SYS HAS BEEN AWARDED "BEST INTERNATIONAL DRUG DEVELOPMENT AND DISCOVERY DEVELOPMENT COMPANY, 2019" BY GHP !

A different approach, Our pharmacology platforms have been designed to accept different entity sources such as :
Plant(s)
Simplified Plant Extracts
(SPE)
Compounds
(natural or chemical source)

Drug discovery

Neuro-Sys is developing a pipeline of innovative compounds focused on treatments for neurodegenerative diseases, orphan diseases and auto-immune diseases, both internally and through collaborations. We identify our lead compounds using our innovative and cutting-edge technology platform, including our internal manufacturing process.

More